MAGEE-WOMENS RESEARCH ROUNDUP: SEPTEMBER 2023
Sep 30, 2023
What's the latest in women's health? What’s the newest research in reproductive biology? How does the environment impact health?
Find insights and innovations in the Magee-Womens Research Institute Research Roundup, a monthly update on recently published findings in women’s health and reproductive biology research from Magee-Womens investigators.
Below is a roundup of key publications released in September 2023.
Predictions for Prenatal Care
Carl Hubel and colleagues found that both pro-inflammatory and anti-inflammatory markers were elevated in obese pregnant individuals during the first and second trimester, who later developed preeclampsia (American Journal of Reproductive Immunology).
HIV Future is Tenofovir Film
Dr. Sravan Patel, Dr. Lisa Rohan, and their team used non-human primates to show the stability, safety, and efficient drug delivery of tenofovir films in the cervicovaginal compartments (Frontiers in Reproductive Health).
The Weight of Sleep
Dr. Francesca Facco conducted a study using secondary data analysis, exploring the connection between mid-pregnancy sleep health indicators and gestational weight gain (Paediatric and Perinatal Epidemiology).
Progress in Ovarian Cancer Research
Dr. Ron Buckanovich and team shed light on possible chemo-preventive agents for BRCA1/2 mutation carriers through ovarian cancer culture and organoid-based data (Gynecologic Oncology).
Fishy Phenomenon
Dr. Ron Buckanovich and PSB (Erie) colleagues combined environmental monitoring and pharmacokinetic modeling to estimate dietary fish polychlorinated biphenyls accumulation in humans, with a focus on site-specific and tissue-specific exposures (Environmental Pollution).
The Limits of Viability
Dr. Hy Simhan and colleagues provided a thought-provoking perspective on controversies related to fetal viability determination (Obstetrics and Gynecology).
Empowering Early Detection
Dr. Richard Guido and team shared recommendations for cervical and anal cancer screening and prevention, risk-based management of abnormal cervical cancer screening tests, and emerging treatment options for cervical dysplasia and early cervical cancer (Clinical Obstetrics and Gynecology).
Don’t miss out! Check back next month for the next #RESEARCHROUNDUP.